{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:07:51Z","timestamp":1790226471944,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T00:00:00Z","timestamp":1497398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178939","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T17:38:09Z","timestamp":1497461889000},"page":"e0178939","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival"],"prefix":"10.1371","volume":"12","author":[{"given":"Ozkan","family":"Gungor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi Umut","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydin","family":"Guclu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Gezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfun","family":"Eyileten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Bet\u00fcl","family":"Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orcun","family":"Altunoren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertugrul","family":"Erken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Oguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Kocyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut Ilker","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,14]]},"reference":[{"issue":"7","key":"ref1","first-page":"e0158765","article-title":"PLoS One","volume":"11","author":"NR Hill","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1681\/ASN.2008080860","article-title":"Prediction, progression, and outcomes of chronic kidney disease in older adults","volume":"20","author":"S Anderson","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"Suppl 1","key":"ref3","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.2215\/CJN.02720409","article-title":"Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal","volume":"4","author":"JJ Carrero","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.09231010","article-title":"Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes","volume":"6","author":"MI Yilmaz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2215\/CJN.08660813","article-title":"The relationship between IL-10 levels and cardiovascular events in patients with CKD","volume":"9","author":"MI Yilmaz","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3109\/00365513.2011.598944","article-title":"The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy","volume":"71","author":"A Taslipinar","year":"2011","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.116.308030","article-title":"Chronic Heart Failure and Inflammation: What Do We Really Know?","volume":"119","author":"SA Dick","year":"2016","journal-title":"Circ Res"},{"issue":"23","key":"ref8","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.2174\/0929867322666150415152532","article-title":"Inflammatory Biomarkers and Therapeutic Targets in Heart Failure","volume":"22","author":"L Papadimitriou","year":"2015","journal-title":"Curr Med Chem"},{"issue":"4","key":"ref9","first-page":"293","article-title":"Cardiovascular Disease Consequences of CKD (2016)","volume":"36","author":"AS Go","journal-title":"Semin Nephrol"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.115.018713","article-title":"Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease","volume":"133","author":"M Tonelli","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2147\/VHRM.S1094","article-title":"Early vascular aging (EVA): consequences and prevention","volume":"4","author":"PM Nilsson","year":"2008","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ajh\/hpu225","article-title":"Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification","volume":"28","author":"M Agharazii","year":"2015","journal-title":"Am J Hypertens"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"e013846","DOI":"10.1371\/journal.pone.0138461","article-title":"Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study","volume":"10","author":"K Ioannou","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","article-title":"The IL-33\/ST2 axis: Role in health and disease","volume":"26","author":"M De la Fuente","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation","volume":"42","author":"AB Molofsky","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.smim.2013.10.006","article-title":"Special aspects of interleukin-33 and the IL-33 receptor complex","volume":"25","author":"MU Martin","year":"2013","journal-title":"Semin Immunol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mmr.2015.4516","article-title":"IL\u201133 and kidney disease (Review)","volume":"13","author":"F Yang","year":"2016","journal-title":"Mol Med Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"967826","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"A Ozkok","year":"2014","journal-title":"Biomed Res Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.09.021","article-title":"Soluble ST2 in heart failure","volume":"443","author":"B Dieplinger","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pharmthera.2011.02.005","article-title":"The IL-33\/ST2 pathway\u2014A new therapeutic target in cardiovascular disease","volume":"131","author":"AM Miller","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"15314","DOI":"10.3390\/molecules181215314","article-title":"A novel cardiac bio-marker: ST2: a review","volume":"18","author":"MM Ciccone","year":"2013","journal-title":"Molecules"},{"issue":"4","key":"ref22","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"AS Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"8828","key":"ref26","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","article-title":"Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis","volume":"340","author":"DS Celermajer","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"MC Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1871523014666150514102027","article-title":"An update on Anti-inflammatory Compounds: A Review","volume":"14","author":"AK Dhingra","year":"2015","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP68001","article-title":"Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences","volume":"68","author":"MI Yilmaz","year":"2007","journal-title":"Clin Nephrol.l"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1525-139X.2010.00784.x","article-title":"Inflammation in end-stage renal disease\u2014what have we learned in 10 years?","volume":"23","author":"JJ Carrero","year":"2010","journal-title":"Semin Dial"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000126926","article-title":"Cytokine dysregulation in chronic kidney disease: how can we treat it?","volume":"26","author":"JJ Carrero","year":"2008","journal-title":"Blood Purif"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cyto.2013.05.023","article-title":"Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness","volume":"64","author":"K Yong","year":"2013","journal-title":"Cytokine."},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.162.9.5506","article-title":"Ischemia\/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18","volume":"162","author":"MA Daemen","year":"1999","journal-title":"J Immunol."},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"C Garlanda","year":"2013","journal-title":"Immunity."},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cytogfr.2015.07.017","article-title":"The IL-33\/ST2 axis: Role in health and disease","volume":"26","author":"M De la Fuente","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in Tissue Homeostasis, Injury, and","volume":"42","author":"AB Molofsky","year":"2015","journal-title":"Inflammation. Immunity"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-2600(13)70261-3","article-title":"Role of interleukin 33 in respiratory allergy and asthma","volume":"2","author":"H Makrinioti","year":"2014","journal-title":"Lancet Respir Med."},{"issue":"9","key":"ref38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.humimm.2013.06.029","article-title":"IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy","volume":"74","author":"WD Xu","year":"2013","journal-title":"Hum Immunol"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1681\/ASN.2010091011","article-title":"IL-33 exacerbates acute kidney injury","volume":"22","author":"A Akcay","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10875-011-9622-7","article-title":"Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease","volume":"32","author":"YS Bao","year":"2012","journal-title":"J Clin Immunol"},{"issue":"8","key":"ref41","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2215\/CJN.01260211","article-title":"Flow-mediated vasodilation in end-stage renal disease","volume":"6","author":"FH Verbeke","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"e0138461","DOI":"10.1371\/journal.pone.0138461","article-title":"Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study","volume":"10","author":"K Ioannou","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.102.9.1000","article-title":"Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease","volume":"102","author":"S Fichtlscherer","year":"2000","journal-title":"Circulation."},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/cs0980531","article-title":"Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease","volume":"98","author":"SJ Cleland","year":"2000","journal-title":"Clin Sci (Lond)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2015.07.012","article-title":"IL-33 and IL-4 impair barrier functions of human vascular endothelium via different mechanisms","volume":"73","author":"M Chalubinski","year":"2015","journal-title":"Vascul Pharmacol"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10741-010-9168-4","article-title":"Proinflammatory cytokines in heart failure: double-edged swords","volume":"15","author":"M Hedayat","year":"2010","journal-title":"Heart Fail Rev"},{"issue":"8","key":"ref47","first-page":"333","article-title":"C-reactive protein, cytokines and inflammation in cardiovascular diseases","volume":"109","author":"M Bucova","year":"2008","journal-title":"Bratisl Lek Listy."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.03.020","article-title":"Components of the interleukin-33\/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature","volume":"60","author":"S Demyanets","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.5604\/17322693.1109218","article-title":"Biological role of Interleukin 33 and its importance in pathophysiology of cardiovascular system]","volume":"68","author":"A Czyzewska-Buczy\u0144ska","year":"2014","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"8","key":"ref50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5603\/KP.a2014.0085","article-title":"Soluble ST2 protein in the short-term prognosis after hospitalisation in chronic systolic heart failure","volume":"72","author":"K Wojtczak-Soska","year":"2014","journal-title":"Kardiol Pol"},{"issue":"4","key":"ref51","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.25011\/cim.v36i4.19957","article-title":"Levels of interleukin-33 and interleukin-6 in patients with acute coronary syndrome or stable angina","volume":"36","author":"CL Liu","year":"2013","journal-title":"Clin Invest Med"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijcard.2012.12.059","article-title":"Expression of interleukin-33 and ST2 in nonrheumatic aortic valve stenosis","volume":"168","author":"H Sawada","year":"2013","journal-title":"Int J Cardiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2840-10-101","article-title":"Toll\/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction","volume":"10","author":"E Fousteris","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"ref54","first-page":"501","article-title":"Soluble ST2: A Novel Prognostic Biomarker of Heart Failure","volume":"30","author":"YC Tung","year":"2014","journal-title":"Acta Cardiol Sin"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"e0142141","DOI":"10.1371\/journal.pone.0142141","article-title":"Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events","volume":"10","author":"H Mansell","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:23:04Z","timestamp":1692840184000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178939"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,14]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178939","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,14]]}}}